August 8, 2022
UCB Japan’s E Keppra for IV Infusion (levetiracetam) is now eligible for health coverage for its use in “status epilepticus,” the Ministry of Health, Labor and Welfare said in a notification issued on August 4. In the notification, the ministry...read more